SAD

Ketamine treatment for refractory anxiety: A systematic review

Jamie L. Tully, Amelia D. Dahlén, Connor J. Haggarty, Helgi B. Schiöth, Samantha Brooks First published: 04 May 2022 | https://doi.org/10.1111/bcp.15374 Abstract There is a growing interest in the psychiatric properties of the dissociative anaesthetic ketamine, as single doses have been shown to have fast-acting mood-enhancing and anxiolytic effects, which persist for up to a …

Ketamine treatment for refractory anxiety: A systematic review Read More »

Ketamine: A Promising Novel Therapy for Anxiety and PTSD

In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

Paul Glue, Shona M Neehoff, Natalie J Medlicott, Andrew Gray, Guy Kibby, Neil McNaughton First Published March 21, 2018 | https://doi.org/10.1177/0269881118762073 Abstract Objective: In this maintenance treatment study, we sought to evaluate the effect on anxiety ratings, safety and tolerability of 3 months of weekly ketamine in 20 patients with treatment-refractory DSM IV generalised anxiety disorder …

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders Read More »